Free Trial

Alps Advisors Inc. Grows Stock Position in AMERISAFE, Inc. (NASDAQ:AMSF)

AMERISAFE logo with Finance background

Alps Advisors Inc. lifted its stake in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 7.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 106,697 shares of the insurance provider's stock after acquiring an additional 7,686 shares during the quarter. Alps Advisors Inc. owned approximately 0.56% of AMERISAFE worth $5,607,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in AMSF. Charles Schwab Investment Management Inc. grew its stake in shares of AMERISAFE by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 661,795 shares of the insurance provider's stock valued at $34,109,000 after acquiring an additional 21,799 shares during the period. Raymond James Financial Inc. bought a new position in shares of AMERISAFE during the 4th quarter valued at approximately $9,708,000. Amundi grew its stake in shares of AMERISAFE by 169.2% during the 4th quarter. Amundi now owns 9,210 shares of the insurance provider's stock valued at $456,000 after acquiring an additional 5,789 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of AMERISAFE during the 4th quarter valued at approximately $485,000. Finally, Royce & Associates LP bought a new position in shares of AMERISAFE during the 4th quarter valued at approximately $15,738,000. 97.41% of the stock is currently owned by institutional investors.

AMERISAFE Stock Up 1.5%

AMSF stock traded up $0.66 during midday trading on Monday, hitting $44.82. The company's stock had a trading volume of 103,925 shares, compared to its average volume of 100,543. AMERISAFE, Inc. has a 12 month low of $42.48 and a 12 month high of $60.24. The firm has a market capitalization of $853.82 million, a price-to-earnings ratio of 18.07 and a beta of 0.40. The company has a 50 day moving average of $45.45 and a two-hundred day moving average of $48.61.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.01. AMERISAFE had a return on equity of 16.41% and a net margin of 15.76%. The business had revenue of $83.78 million during the quarter, compared to the consensus estimate of $76.66 million. On average, analysts anticipate that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.

AMERISAFE Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 13th were paid a $0.39 dividend. The ex-dividend date of this dividend was Friday, June 13th. This represents a $1.56 annualized dividend and a yield of 3.48%. AMERISAFE's payout ratio is 62.90%.

Wall Street Analyst Weigh In

Separately, JMP Securities reiterated a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a research note on Wednesday, April 30th.

Get Our Latest Research Report on AMERISAFE

AMERISAFE Profile

(Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Featured Stories

Institutional Ownership by Quarter for AMERISAFE (NASDAQ:AMSF)

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines